SCHEMBL959372

SCHEMBL959372

COC(=O)c1cccc(-c2cc(-c3ccc(Br)cc3)on2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.65
MAPT P10636 1/20 0.65
PTPN1 P18031 1/20 0.52
NPC1 O15118 6/20 0.51
RAB9A P51151 6/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HTT P42858 1/20 0.51
PPARA Q07869 3/20 0.49
PLAU P00749 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
PPARG P37231 2/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
PRKD1 Q15139 2/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209891 0.91 NPC1 (0.57) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL937517 0.90 NPC1 (0.59) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12171803 0.89 NPC1 (0.65) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL1505201 0.89 NPC1 (0.58) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12171384 0.89 NPC1 (0.52) TP53MAPTNPC1RAB9APPARA
SCHEMBL960012 0.87 NPC1 (0.52) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL960027 0.86 PRKD1 (0.51) TP53MAPTNPC1RAB9APPARA
SCHEMBL12171582 0.86 MAPT (0.53) TP53MAPTNPC1RAB9APPARA
SCHEMBL12171453 0.86 TP53 (0.48) TP53MAPTNPC1RAB9APPARA
SCHEMBL937384 0.86 ALDH1A1 (0.51) TP53MAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed